Granular cell tumors (GCT) of the esophagus are rare. The tumor is generall
y beleived to be of neurogenic origin and shows a malignant course in 2-4%
of cases. No unanimity has been reached regarding the management of this tu
mor. A national survey was conducted on the incidence of GCT of the esophag
us, related symptoms, management, and follow-up. A national survey was perf
ormed on all newly registered esophageal GCTs in the PALGA system (Dutch re
gister of all pathology diagnoses) for seven consecutive years (1988-1994).
Fifty-two new cases (17 men, 35 women; median age 46 years, range 22-77 ye
ars) were registered. In 44 cases clinical data could be obtained (survey r
esponse 85%). The majority of the GCTs were solitary (42/44) and localized
in the distal esophagus (33/44). At endoscopy the size of the tumor was est
imated at <5 mm. in 50%, 5-10 mm in 25%, and 10-30 mm in 18%. Most patients
(40/44) presented with nonspecific gastrointestinal symptoms, only four ha
d dysphagia (tumor size >1 cm). No malignancies were reported. Management o
f the tumor included excisional biopsy (1/44), endoscopic polypectomy (3/44
), and surgical excision (1/44). Endoscopic follow up (1-60 months) in 16 o
ut of 17 patients left untreated showed either a stable tumor size or regre
ssion of the tumor. In one case with multiple GCT's a slight tumor growth w
as seen after a follow-up period of 48 months. Esophageal GCTs in the Nethe
rlands are rare, and mostly diagnosed incidentally. Most patients suffer fr
om nonspecific symptoms; dysphagia occurs only with tumors >1 cm. The usual
clinical course of esophageal GCTs is benign. Patients without dysphagia p
robably do not require routine endoscopic follow-up, provided they are inst
ructed to contact their physician, once dysphagia develops.